Innovative Strategies for the Treatment of CLL
- 1 January 1996
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 22 (sup2) , 53-64
- https://doi.org/10.3109/10428199609102703
Abstract
(1996). Innovative Strategies for the Treatment of CLL. Leukemia & Lymphoma: Vol. 22, No. sup2, pp. 53-64.Keywords
This publication has 10 references indexed in Scilit:
- Topotecan in chronic lymphocytic leukemiaCancer, 1995
- Loxoribine induces chronic lymphocytic leukemia B cells to traverse the cell cycleBlood, 1994
- Chemosensitivity of lymphocytes from patients with B-cell chronic lymphocytic leukemia to chlorambucil, fludarabine, and camptothecin analogsBlood, 1994
- Clinical Experience with Fludarabine in LeukaemiaDrugs, 1994
- Autologous and allogeneic bone marrow transplantation for poor prognosis patients with B-cell chronic lymphocytic leukemiaBlood, 1993
- Chronic Lymphocytic Leukemia—Correlation of Response and SurvivalLeukemia & Lymphoma, 1993
- Retinoids in cancer prevention and therapyAnnals of Oncology, 1992
- Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis [see comments]Blood, 1992
- Evaluation of Residual Disease in B-Cell Chronic Lymphocytic Leukemia Patients in Clinical and Bone-Marrow Remission Using CD5-CD19 Markers and PCR Study of Gene RearrangementsLeukemia & Lymphoma, 1992
- Immunologic and molecular evaluation of residual disease in b-cell chronic lymphocytic leukemia patients in clinical remission phaseCancer, 1989